Kudo Capsule Clinical analysis of menorrhagia.docVIP

 PAGE \* MERGEFORMAT 7 Kudo Capsule Clinical analysis of menorrhagia [Keywords:] Kudo capsule menorrhagia Kudo capsule has hemostatic and analgesic effect. I expanded through a multi-center clinical trial to further observe the treatment of menorrhagia Duyiwei capsule effectiveness and safety of its making an objective evaluation. 1 Experimental Design 1.1 Test methods A randomized, single blind, positive parallel controlled, multicenter clinical trial. 1.2 Drugs Test drugs: Kudo capsules, pharmaceutical Co., Ltd. Gansu Kudo production, batch number size: 0.3 g / grain. Controlled drugs: Yunnanbaiyao capsules, Yunnan Baiyao Group Co., Ltd. production, batch number size: 0.25 g / grain. 1.3 treatment methods Test group: single blind oral capsules, 3 times a day, 3 capsules each time. Control group: oral Yunnanbaiyao capsules, 4 times a day, each time 2. Treatment: 7 d to a course of treatment. 2 Case Selection Inclusion criteria: ① Western diagnostic criteria consistent with menorrhagia [1], ② blood stasis Syndrome meet diagnostic criteria [1], ③ age from 14 to 50 year-old female, ④ informed consent, voluntary subjects. Comply with the above four standards can be incorporated into test cases. Exclusion and exclusion criteria: ① The inspection confirmed the pregnancy, cancer, Sheung Wan, trauma or systemic disease caused by bleeding, ② the age of 14 years of age, 50 years of age, or breast-feeding women, ③ merger determination, brain, liver, kidney and hematopoietic system and other serious diseases, ④ the mentally ill, ⑤ of the drug allergy; ⑥ do not meet the inclusion criteria, according to the specified medication, can not determine the efficacy or impact of incomplete information such as efficacy and safety of judges. 3 Observation and Evaluation Indicators 3.1 Effectiveness Evaluation Observation of menstrual flow, color, quality and duration, and associated symptoms and tongue, pulse changes.